NET PROFIT (x1000 EUR)
EMPLOYEES
Frederiksstaden Pharma ApS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-11
|
1
|
-272 |
| Total assets |
44
|
36
|
99 |
| Current assets |
4
|
36
|
99 |
| Current liabilities |
24
|
4
|
69 |
| Equity capital |
20
|
31
|
31 |
| - share capital |
21
|
21
|
21 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
45.5%
|
86.1%
|
31.3% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
16.7%
|
900%
|
143.5% |
| Return on equity (ROE) |
-55.0%
|
3.2%
|
-877.4% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.